Sept. 7, 2023

Monica Bertagnolli, MD, President Biden’s nominee to lead the National Institutes of Health (NIH) recently pledged to not seek employment or compensation from any of the world’s largest pharmaceutical companies for four years once she leaves the government. Dr. Bertagnolli’s nomination for NIH Director was announced in May and has not yet been raised to the Senate Committee on Health, Education, Labor and Pensions (HELP) for review. The American College of Radiology® (ACR®) previously joined 115 organizations in a letter of support of the nomination of Dr. Bertagnolli to lead the NIH.

Dr. Bertagnolli’s agreement to not seek employment or compensation from pharmaceutical companies may show progress in her currently stalled nomination process. Sen. Elizabeth Warren, who held concerns about the nomination, now says she will support Dr. Bertagnolli’s nomination. Previously, Sen. Bernie Sanders, the HELP Committee Chair, stated he would not progress with the nomination pending the Biden administration’s drug pricing negotiations. There has not been an update on the status of Sen. Sander’s considerations nor an announcement of when the Senate will move forward with the nomination.

For more information, contact Katie Grady, ACR Government Affairs Director.


Related ACR News

  • State Legislative Bills Report

    As most state legislatures end their 2025 sessions and look to 2026, ACR staff is looking at how some radiology-specific bills they tracked fared this year.

    Read more
  • Medicare Payment Increase in Final Budget Reconciliation Bill

    The bill includes a 2.5% increase to the Medicare Physician Fee Schedule for calendar year 2026.

    Read more
  • CMS Announces Prior Authorization Test Model

    WiSer is a six-year program that will begin in six states on January 1, 2026. It will introduce prior authorization using AI technology for a select number of services, including some IR procedures.

    Read more